Construction of a Nomogram-Based Prediction Model for the Risk of Diabetic Kidney Disease in T2DM.

Authors:
Wang X; Liu X; Zhao J; Chen M; Wang L.

Journal:
Diabetes Metab Syndr Obes

Publication Year: 2024

DOI:
10.2147/DMSO.S442925

PMCID:
PMC10790646

PMID:
38229907

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Diabetes Metab Syndr Obes

Abbreviation: Diabetes Metab Syndr Obes

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology & Metabolism

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Associations of Serum Uric Acid to High-Density Lipoprotein Cholesterol Ratio with Trunk Fat Mass a…
Wang Y; Xu Y; Hu T and 5 more (2024) - Transparency Score: 3/6
A Systematic Review of the Economic Burden of Diabetes in Eastern Mediterranean Region Countries.
Arshad MS; Alqahtani F; Rasool MF. (2024) - Transparency Score: 4/6
Claudin-2 Mediates the Proximal Tubular Epithelial Cell-Fibroblast Crosstalk via Paracrine CTGF.
Guo C; Jiao M; Cui Y and 4 more (2024) - Transparency Score: 3/6
Clinical Evidence of the Relationship Between Alanine Aminotransferase and Diabetic Kidney Disease.
Bi Y; Yang Y; Yuan X and 4 more (2024) - Transparency Score: 3/6
Correlation Between Glycolipid Metabolism Levels and Diabetic Retinopathy in Patients with Type 2 D…
Wang S; Pan X; Zhang M and 1 more (2024) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure The authors declare that they have no conflicts of interest in relation to this work."

Evidence found in paper:

"This study was not funded."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025